Literature DB >> 29194321

Variability in management of blunt liver trauma and contribution of level of American College of Surgeons Committee on Trauma verification status on mortality.

Christopher J Tignanelli1, Bellal Joseph, Jill L Jakubus, Gaby A Iskander, Lena M Napolitano, Mark R Hemmila.   

Abstract

BACKGROUND: Patients who sustain blunt liver trauma and are treated at an American College of Surgeons Committee on Trauma-verified Level I trauma center have an overall lower risk of mortality compared with patients admitted to a level II trauma center. However, elements contributing to these differences are unknown. We hypothesize that practice variation exists between trauma centers in management of blunt liver injury. Our objective is to identify practice variations and their effect on clinical outcomes.
METHODS: Data from a statewide collaborative quality initiative for trauma were used. The data set contains information from 29 American College of Surgeons Committee on Trauma verified Levels I and II trauma centers from 2011 to 2016. Propensity score matching was used to create cohorts of patients treated at Levels I or II trauma centers. The 1:1 matched cohorts were used to compare in-hospital mortality, management strategy, complications, intensive care unit (ICU) and hospital length of stay, and failure to rescue.
RESULTS: Four hundred fifty-four patients with grade 3 or higher blunt liver injury were included. Patients treated at level II trauma centers had higher in-hospital mortality than those treated at Level I trauma centers (15.4% vs 8.8%, p = 0.03). Level II trauma centers used angiography less compared with Level I centers (p = 0.007) and admitted significantly fewer patients to the ICU (p = 0.002). The ICU status was associated with reduced mortality (7.2% vs 23.9%, p < 0.001). Despite a lower rate of overall complications, Level II trauma centers were more likely to fail in rescuing their patients (p = 0.045).
CONCLUSION: Admission with a high-grade liver injury to a Level II trauma center is associated with increased in-hospital mortality. Level II trauma centers were less likely to use angiography or admit high-grade liver injuries to the ICU. This variation in practice may lead to the inability to rescue critically ill patients. Future research should investigate contributors to underutilization of resources for patients with high-grade liver injuries. LEVEL OF EVIDENCE: Care management, level IV.

Entities:  

Mesh:

Year:  2018        PMID: 29194321     DOI: 10.1097/TA.0000000000001743

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  Surgical repair of perforated peptic ulcers: laparoscopic versus open approach.

Authors:  Victor Vakayil; Brent Bauman; Keaton Joppru; Reema Mallick; Christopher Tignanelli; John Connett; Sayeed Ikramuddin; James V Harmon
Journal:  Surg Endosc       Date:  2018-07-24       Impact factor: 4.584

2.  Hospital-level intensive care unit admission for patients with isolated blunt abdominal solid organ injury.

Authors:  Jessica A Bowman; Gregory J Jurkovich; Miriam Nuño; Garth H Utter
Journal:  J Trauma Acute Care Surg       Date:  2020-03       Impact factor: 3.697

3.  Factors associated with optimal patient outcomes after operative repair of isolated hip fractures in the elderly.

Authors:  Alirio J deMeireles; Laura Gerhardinger; Bryant W Oliphant; Peter C Jenkins; Anne H Cain-Nielsen; John W Scott; Mark R Hemmila; Naveen F Sangji
Journal:  Trauma Surg Acute Care Open       Date:  2020-12-22

4.  Racial Disparities at Mixed-Race and Minority Hospitals : Treatment of African American Males With High-Grade Splenic Injuries.

Authors:  Christopher J Tignanelli; Bradly Watarai; Yunhua Fan; Ashley Petersen; Mark Hemmila; Lena Napolitano; Stephanie Jarosek; Anthony Charles
Journal:  Am Surg       Date:  2020-09-15       Impact factor: 1.002

Review 5.  Liver trauma: WSES 2020 guidelines.

Authors:  Federico Coccolini; Raul Coimbra; Carlos Ordonez; Yoram Kluger; Felipe Vega; Ernest E Moore; Walt Biffl; Andrew Peitzman; Tal Horer; Fikri M Abu-Zidan; Massimo Sartelli; Gustavo P Fraga; Enrico Cicuttin; Luca Ansaloni; Michael W Parra; Mauricio Millán; Nicola DeAngelis; Kenji Inaba; George Velmahos; Ron Maier; Vladimir Khokha; Boris Sakakushev; Goran Augustin; Salomone di Saverio; Emanuil Pikoulis; Mircea Chirica; Viktor Reva; Ari Leppaniemi; Vassil Manchev; Massimo Chiarugi; Dimitrios Damaskos; Dieter Weber; Neil Parry; Zaza Demetrashvili; Ian Civil; Lena Napolitano; Davide Corbella; Fausto Catena
Journal:  World J Emerg Surg       Date:  2020-03-30       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.